1. Home
  2. CHRO vs SGN Comparison

CHRO vs SGN Comparison

Compare CHRO & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • SGN
  • Stock Information
  • Founded
  • CHRO 2002
  • SGN 2019
  • Country
  • CHRO United States
  • SGN United States
  • Employees
  • CHRO N/A
  • SGN N/A
  • Industry
  • CHRO
  • SGN
  • Sector
  • CHRO
  • SGN
  • Exchange
  • CHRO Nasdaq
  • SGN Nasdaq
  • Market Cap
  • CHRO 3.9M
  • SGN 4.1M
  • IPO Year
  • CHRO 2024
  • SGN 2023
  • Fundamental
  • Price
  • CHRO $0.66
  • SGN $0.18
  • Analyst Decision
  • CHRO Strong Buy
  • SGN
  • Analyst Count
  • CHRO 1
  • SGN 0
  • Target Price
  • CHRO N/A
  • SGN N/A
  • AVG Volume (30 Days)
  • CHRO 100.6K
  • SGN 4.9M
  • Earning Date
  • CHRO 11-13-2024
  • SGN 11-25-2024
  • Dividend Yield
  • CHRO N/A
  • SGN N/A
  • EPS Growth
  • CHRO N/A
  • SGN N/A
  • EPS
  • CHRO N/A
  • SGN N/A
  • Revenue
  • CHRO N/A
  • SGN $576,488.00
  • Revenue This Year
  • CHRO N/A
  • SGN N/A
  • Revenue Next Year
  • CHRO N/A
  • SGN N/A
  • P/E Ratio
  • CHRO N/A
  • SGN N/A
  • Revenue Growth
  • CHRO N/A
  • SGN 218.74
  • 52 Week Low
  • CHRO $0.52
  • SGN $0.11
  • 52 Week High
  • CHRO $6.00
  • SGN $2.70
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 48.22
  • SGN 42.04
  • Support Level
  • CHRO $0.63
  • SGN $0.18
  • Resistance Level
  • CHRO $0.69
  • SGN $0.29
  • Average True Range (ATR)
  • CHRO 0.06
  • SGN 0.03
  • MACD
  • CHRO 0.01
  • SGN -0.00
  • Stochastic Oscillator
  • CHRO 52.55
  • SGN 18.66

About CHRO Chromocell Therapeutics Corporation

Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain and other associated medical conditions. The company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic neuropathic pain and eye pain. The Company's portfolio also includes pre-clinical work on other sodium channel receptor subtypes, and the company intends to explore these and other compounds for the treatment of additional pain indications.

About SGN Signing Day Sports Inc.

Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.

Share on Social Networks: